133 related articles for article (PubMed ID: 2327316)
1. Increased in vitro release of interleukin-1 by LPS stimulated peritoneal macrophages obtained from patients on continuous ambulatory peritoneal dialysis (CAPD) during an infectious peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL
Agents Actions; 1990 Jan; 29(1-2):30-1. PubMed ID: 2327316
[No Abstract] [Full Text] [Related]
2. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL
Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
Fieren MW; Van den Bemd GJ; Bonta IL
Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta.
Fieren MW; van den Bemd GJ; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):23-8. PubMed ID: 1438464
[TBL] [Abstract][Full Text] [Related]
5. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
[TBL] [Abstract][Full Text] [Related]
6. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
7. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis.
Hart PH; Jones CA; Jones KL; Finlay-Jones JJ
Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():99-107. PubMed ID: 8486401
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis.
Hart PH; Jones CA; Finlay-Jones JJ
J Leukoc Biol; 1993 Mar; 53(3):309-19. PubMed ID: 7681094
[TBL] [Abstract][Full Text] [Related]
9. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
Lin CY; Huang TP
Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
[TBL] [Abstract][Full Text] [Related]
10. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.
Lin CY; Ku WL; Huang TP
Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
Lamperi S; Carozzi S
Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte stimulating factor in patients on peritoneal dialysis and LPS stimulated peripheral blood mononuclear cells.
Brauner A; Hylander B; Lu Y
Inflammation; 1998 Aug; 22(4):393-401. PubMed ID: 9675610
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal membrane defence mechanism in CAPD.
Lamperi S; Carozzi S; Nasini MG
Contrib Nephrol; 1987; 57():69-78. PubMed ID: 3315441
[No Abstract] [Full Text] [Related]
14. Properties of human peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
FEMS Microbiol Immunol; 1989 Apr; 1(5):303-4. PubMed ID: 2631872
[No Abstract] [Full Text] [Related]
15. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.
Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL
Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL; Ben-Efraim S
J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients.
Shany S; Rapoport J; Zuili I; Gavriel A; Lavi N; Chaimovitz C
Kidney Int; 1991 May; 39(5):1005-11. PubMed ID: 2067195
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients.
Carozzi S; Nasini G; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
ASAIO Trans; 1990; 36(3):M369-71. PubMed ID: 2174686
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter.
Locatelli A; Quiroga MA; De Benedetti L; Gomez M; Barone R; Barron MC
Adv Perit Dial; 1995; 11():176-8. PubMed ID: 8534698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
